Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

Ovarian cancer

  • Open Access
    Pan-cancer Analysis Reveals Cancer-dependent Expression of SOX17 and Associated Clinical Outcomes
    LI XU, YOUHUANG BAI, YIHANG CHENG, XIUJIE SHENG and DEQIANG SUN
    Cancer Genomics & Proteomics September 2023, 20 (5) 433-447; DOI: https://doi.org/10.21873/cgp.20395
  • Open Access
    TMED9 Expression Level as a Biomarker of Epithelial Ovarian Cancer Progression and Prognosis
    GWAN HEE HAN, HEE YUN, JOON-YONG CHUNG, JAE-HOON KIM and HANBYOUL CHO
    Cancer Genomics & Proteomics November 2022, 19 (6) 692-702; DOI: https://doi.org/10.21873/cgp.20352
  • Open Access
    Cell Cycle Regulator p27 Mediates Body Mass Index Effects in Ovarian Cancer in FIGO-stages I-II
    INGIRIDUR SKIRNISDOTTIR, HELENA AKERUD, TOMAS SEIDAL and INGER SUNDSTROM-POROMAA
    Cancer Genomics & Proteomics November 2019, 16 (6) 443-450; DOI: https://doi.org/10.21873/cgp.20148
  • Open Access
    Regulation of REG4 Expression and Prediction of 5-Fluorouracil Sensitivity by CDX2 in Ovarian Mucinous Carcinoma
    IEMASA KOH, SUGURU NOSAKA, MASAKI SEKINE, JUN SUGIMOTO, EIJI HIRATA and YOSHIKI KUDO
    Cancer Genomics & Proteomics November 2019, 16 (6) 481-490; DOI: https://doi.org/10.21873/cgp.20151
  • Open Access
    Leptin Receptor Antagonists' Action on HDAC Expression Eliminating the Negative Effects of Leptin in Ovarian Cancer
    ELŻBIETA FIEDOR, KAROLINA ZAJDA and EWA L. GREGORASZCZUK
    Cancer Genomics & Proteomics July 2018, 15 (4) 329-336; DOI: https://doi.org/10.21873/cgp.20091
  • Open Access
    Proteomics Analysis of Ovarian Cancer Cell Lines and Tissues Reveals Drug Resistance-associated Proteins
    ISA N. CRUZ, HELEN M. COLEY, HOLGER B. KRAMER, THUMULURU KAVITAH MADHURI, NUR A.M. SAFUWAN, ANA RITA ANGELINO and MIN YANG
    Cancer Genomics & Proteomics January 2017, 14 (1) 35-51;
  • Open Access
    A Low-density Antigen Array for Detection of Disease-associated Autoantibodies in Human Plasma
    RICHARD I. SOMIARI, REBECCA SUTPHEN, KUTRALANATHAN RENGANATHAN, STEPHEN RUSSELL, ELZBIETA PASTWA and STELLA A. SOMIARI
    Cancer Genomics & Proteomics January 2016, 13 (1) 13-19;
  • You have access
    Association of p21, p21 p27 and p21 p53 Status to Histological Subtypes and Prognosis in Low-stage Epithelial Ovarian Cancer
    INGIRIDUR SKIRNISDOTTIR and TOMAS SEIDAL
    Cancer Genomics & Proteomics January 2013, 10 (1) 27-34;
Cancer & Genome Proteomics

© 2023 Cancer Genomics & Proteomics

Powered by HighWire